Dermatology Doctors in Fall River, MA Accepting Medicare

4 Dermatology doctors found. Showing 1 - 4

Dr. Arthur David Daily, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1010 S Main St, Fall River, MA 02724 Phone: 508-225-5450    Fax: 508-235-5452

Marina Kuperman-beade, M.D., F.A.A.D. Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1030 President Ave Ste 306, Fall River, MA 02720 Phone: 401-751-7546    Fax: 401-751-6888

David Brooks Walker, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1030 President Ave, Suite 114, Fall River, MA 02720 Phone: 508-676-3411    Fax: 508-235-6340

Dr. Richard N Waldman, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1151 Robeson St Ste 201, Fall River, MA 02720 Phone: 508-730-1666

News Archive

New cough suppressant from cocoa

People suffering from persistent cough may soon have a remedy that is derived from cocoa. At present researchers are carrying out the final stages of clinical trials of a drug that contains theobromine, an ingredient found in chocolate and cocoa. The drug could be in the market in another two years.

Kaiser Family Foundation releases primer on U.S. engagement in global health issues

A new Kaiser Family Foundation primer "provides a comprehensive overview of the U.S. government's engagement in global health issues, including a look at the federal programs that support these efforts," according to an email alert from the foundation.

MedAvante's centralized ratings to be used in Rexahn's Serdaxin Phase 2a study in MDD patients

MedAvante, Inc., the leader in centralized expert evaluation of central nervous system (CNS) disorders, and Rexahn Pharmaceuticals, Inc. a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, announced that Rexahn will use MedAvante 's Remote Centralized Ratings™ in their randomized, double-blind, placebo-controlled Phase 2b clinical study assessing the efficacy of Serdaxin® in patients with major depressive disorder (MDD).

Nanofiber Solutions wins Ohio Third Frontier Technology Validation and Start-up Fund award

Nanofiber Solutions, LLC, in collaboration with Gail E. Besner, MD, chief of Pediatric Surgery, program director of the Residency in Pediatric Surgery and co-director of the Burn Program all at Nationwide Children's Hospital, recently was honored with the Ohio Third Frontier Technology Validation and Start-up Fund award.

Black patients in most segregated areas more likely to receive surgery at low-quality hospitals

Black patients are more likely to have surgery performed at low-quality hospitals even though they frequently live closer to better facilities than white patients.

Read more Medical News

› Verified 6 days ago